{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T05:45:20Z","timestamp":1759383920157},"reference-count":11,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,7,29]]},"DOI":"10.7759\/cureus.42654","type":"journal-article","created":{"date-parts":[[2023,7,29]],"date-time":"2023-07-29T16:06:41Z","timestamp":1690646801000},"source":"Crossref","is-referenced-by-count":4,"title":["Phenytoin-Induced Toxic Epidermal Necrolysis"],"prefix":"10.7759","author":[{"given":"Mounika Nagarani","family":"Tunuguntla","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pranathi","family":"Chanti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tanishq","family":"Kesani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kusuma","family":"Yarapathineni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prithvi","family":"Kukkadapu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1186\/s12948-016-0045-0","article-title":"Drug induced exfoliative dermatitis: state of the art","volume":"14","author":"Yacoub MR","year":"2016","unstructured":"Yacoub MR, Berti A, Campochiaro C, et al.. Drug induced exfoliative dermatitis: state of the art. Clin Mol Allergy. 2016, 14:9. 10.1186\/s12948-016-0045-0","journal-title":"Clin Mol Allergy"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3390\/medicina57090895","article-title":"Stevens-Johnson syndrome and toxic epidermal necrolysis: a review of diagnosis and management","volume":"57","author":"Frantz R","year":"2021","unstructured":"Frantz R, Huang S, Are A, Motaparthi K. Stevens-Johnson syndrome and toxic epidermal necrolysis: a review of diagnosis and management. Medicina (Kaunas). 2021, 57:895. 10.3390\/medicina57090895","journal-title":"Medicina (Kaunas)"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1111\/1346-8138.12674","article-title":"Immunological response in Stevens-Johnson syndrome and toxic epidermal necrolysis","volume":"42","author":"Abe R","year":"2015","unstructured":"Abe R. Immunological response in Stevens-Johnson syndrome and toxic epidermal necrolysis. J Dermatol. 2015, 42:42-8. 10.1111\/1346-8138.12674","journal-title":"J Dermatol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.2010.03764.x","article-title":"Delayed drug hypersensitivity: models of T-cell stimulation","volume":"71","author":"Adam J","year":"2011","unstructured":"Adam J, Pichler WJ, Yerly D. Delayed drug hypersensitivity: models of T-cell stimulation. Br J Clin Pharmacol. 2011, 71:701-7. 10.1111\/j.1365-2125.2010.03764.x","journal-title":"Br J Clin Pharmacol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.12788\/j.sder.0058","article-title":"Stevens-Johnson syndrome and toxic epidermal necrolysis: clinical patterns, diagnostic considerations, etiology, and therapeutic management","volume":"33","author":"Mockenhaupt M","year":"2014","unstructured":"Mockenhaupt M. Stevens-Johnson syndrome and toxic epidermal necrolysis: clinical patterns, diagnostic considerations, etiology, and therapeutic management. Semin Cutan Med Surg. 2014, 33:10-6. 10.12788\/j.sder.0058","journal-title":"Semin Cutan Med Surg"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.15562\/bmj.v5i1.274","article-title":"Topical treatment for Stevens-Johnson syndrome and toxic epidermal necrolysis: a review","volume":"5","author":"Purnamawati S","year":"2016","unstructured":"Purnamawati S, Febriana SA, Danarti R, Saefudin T. Topical treatment for Stevens-Johnson syndrome and toxic epidermal necrolysis: a review. Bali Med J. 2016, 5:82-90. 10.15562\/bmj.v5i1.274","journal-title":"Bali Med J"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1111\/j.1398-9995.2006.01295.x","article-title":"Ocular manifestations and complications of Stevens-Johnson syndrome and toxic epidermal necrolysis: an Asian series","volume":"62","author":"Yip LW","year":"2007","unstructured":"Yip LW, Thong BY, Lim J, Tan AW, Wong HB, Handa S, Heng WJ. Ocular manifestations and complications of Stevens-Johnson syndrome and toxic epidermal necrolysis: an Asian series. Allergy. 2007, 62:527-31. 10.1111\/j.1398-9995.2006.01295.x","journal-title":"Allergy"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2009.09585.x","article-title":"Granulocyte colony-stimulating factor in toxic epidermal necrolysis (TEN) and Chelsea & Westminster TEN management protocol [corrected]","volume":"162","author":"de Sica-Chapman A","year":"2010","unstructured":"de Sica-Chapman A, Williams G, Soni N, Bunker CB. Granulocyte colony-stimulating factor in toxic epidermal necrolysis (TEN) and Chelsea & Westminster TEN management protocol [corrected]. Br J Dermatol. 2010, 162:860-5. 10.1111\/j.1365-2133.2009.09585.x","journal-title":"Br J Dermatol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2016.5668","article-title":"Systemic immunomodulating therapies for Stevens-Johnson syndrome and toxic epidermal necrolysis: a systematic review and meta-analysis","volume":"153","author":"Zimmermann S","year":"2017","unstructured":"Zimmermann S, Sekula P, Venhoff M, Motschall E, Knaus J, Schumacher M, Mockenhaupt M. Systemic immunomodulating therapies for Stevens-Johnson syndrome and toxic epidermal necrolysis: a systematic review and meta-analysis. JAMA Dermatol. 2017, 153:514-22. 10.1001\/jamadermatol.2016.5668","journal-title":"JAMA Dermatol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1097\/00005373-200003000-00017","article-title":"Treatment of toxic epidermal necrolysis with cyclosporin A","volume":"48","author":"Ar\u00e9valo JM","year":"2000","unstructured":"Ar\u00e9valo JM, Lorente JA, Gonz\u00e1lez-Herrada C, Jim\u00e9nez-Reyes J. Treatment of toxic epidermal necrolysis with cyclosporin A. J Trauma. 2000, 48:473-8. 10.1097\/00005373-200003000-00017","journal-title":"J Trauma"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1111\/ajd.12254","article-title":"Role of nanocrystalline silver dressings in the management of toxic epidermal necrolysis (TEN) and TEN\/Stevens-Johnson syndrome overlap","volume":"56","author":"Smith SD","year":"2015","unstructured":"Smith SD, Dodds A, Dixit S, Cooper A. Role of nanocrystalline silver dressings in the management of toxic epidermal necrolysis (TEN) and TEN\/Stevens-Johnson syndrome overlap. Australas J Dermatol. 2015, 56:298-302. 10.1111\/ajd.12254","journal-title":"Australas J Dermatol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/157033-phenytoin-induced-toxic-epidermal-necrolysis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:02:48Z","timestamp":1707508968000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/157033-phenytoin-induced-toxic-epidermal-necrolysis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,29]]},"references-count":11,"URL":"https:\/\/doi.org\/10.7759\/cureus.42654","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7,29]]}}}